FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:80-85 July 9, 1998 Number 2 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Compression stockings are recommended for prophylaxis against venous thromboembolism in patients undergoing neurosurgery, but anticoagulant agents have not gained wide acceptance because of concern about intracranial bleeding.

Methods In a multicenter, randomized, double-blind trial, we assessed the efficacy and safety of enoxaparin in conjunction with the use of compression stockings in the prevention of venous thromboembolism in patients undergoing elective neurosurgery. Enoxaparin (40 mg once daily) or placebo was given subcutaneously for not less than seven days beginning within 24 hours after surgery. The primary end point was symptomatic, objectively confirmed venous thromboembolism or deep-vein thrombosis assessed by bilateral venography, which was performed in all patients on day 8±1. Bleeding side effects were carefully assessed.

Results Among the 307 patients assigned to treatment groups, 129 of the 154 patients receiving placebo (84 percent) and 130 of the 153 patients receiving enoxaparin (85 percent) had venographic studies adequate for analysis. An additional patient in the placebo group died before venography of autopsy-confirmed pulmonary embolism. In this analysis, 42 patients given placebo (32 percent) and 22 patients given enoxaparin (17 percent) had deep-vein thrombosis (relative risk in the enoxaparin group, 0.52; 95 percent confidence interval, 0.33 to 0.82; P=0.004). The rates of proximal deep-vein thrombosis were 13 percent in patients receiving placebo and 5 percent in patients receiving enoxaparin (relative risk in the enoxaparin group, 0.41; 95 percent confidence interval, 0.17 to 0.95; P=0.04). Two patients in the placebo group died of autopsy-confirmed pulmonary embolism on days 9 and 16. Major bleeding occurred in four patients receiving placebo (intracranial bleeding in all four) and four patients (intracranial bleeding in three) receiving enoxaparin (3 percent of each group).

Conclusions Enoxaparin combined with compression stockings is more effective than compression stockings alone for the prevention of venous thromboembolism after elective neurosurgery and does not cause excessive bleeding.

Source Information

From the Istituto di Medicina Interna e Medicina Vascolare, Università di Perugia, and Divisione di Neurochirurgia, Ospedale Silvestrini, Perugia (G.A., P.B., M.D., A.I.); the Clinica Neurochirurgica and Clinica Medica II, Università di Pavia, Pavia (F.P., C.B., R.P., G.B.); the Divisione di Neurochirurgia, Ospedale Galliera, Genoa (P.S., G.C.A.); V Divisione Medica, Azienda Ospedaliera, Parma (M.P.); and the Divisione di Neurochirurgia and Servizio di Coagulazione, Ospedale S. Raffaele, Milan (A.D.) — all in Italy.

Address reprint requests to Professor Agnelli at the Istituto di Medicina Interna e Medicina Vascolare, Università di Perugia, Via Enrico dal Pozzo, 06123 Perugia, Italy.

Full Text of this Article

Related Letters:

Enoxaparin in Neurosurgical Patients
Connolly E. S., Mocco J, Agnelli G., Iorio A.
Extract | Full Text  
N Engl J Med 1998; 339:1639-1640, Nov 26, 1998. Correspondence

This article has been cited by other articles:

• Ploumis, A., Ponnappan, R.K., Maltenfort, M.G., Patel, R.X., Bessey, J.T., Albert, T.J., Harrop, J.S., Fisher, C.G., Bono, C.M., Vaccaro, A.R. (2009). Thromboprophylaxis in Patients with Acute Spinal Injuries: An Evidence-Based Analysis. JBJS 91: 2568-2576 [Abstract] [Full Text]  
• Kakkar, A. K. (2009). Prevention of Venous Thromboembolism in the Cancer Surgical Patient. JCO 27: 4881-4884 [Abstract] [Full Text]  
• PAN, E., TSAI, J. S., MITCHELL, S. B. (2009). Retrospective Study of Venous Thromboembolic and Intracerebral Hemorrhagic Events in Glioblastoma Patients. Anticancer Res 29: 4309-4313 [Abstract] [Full Text]  
• Collen, J. F., Jackson, J. L., Shorr, A. F., Moores, L. K. (2008). Prevention of Venous Thromboembolism in Neurosurgery: A Metaanalysis. Chest 134: 237-249 [Abstract] [Full Text]  
• Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., Colwell, C. W. (2008). Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 381S-453S [Abstract] [Full Text]  
• Corbett, S. M., Rebuck, J. A. (2008). Medication-Related Complications in the Trauma Patient. J Intensive Care Med 23: 91-108 [Abstract]  
• Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., Liebman, H., Mendelson, D., Raskob, G., Somerfield, M. R., Thodiyil, P., Trent, D., Francis, C. W. (2007). American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. JCO 25: 5490-5505 [Abstract] [Full Text]  
• Lacut, K., Bressollette, L., Le Gal, G., Etienne, E., De Tinteniac, A., Renault, A., Rouhart, F., Besson, G., Garcia, J. -F., Mottier, D., Oger, E., on behalf of the VICTORIAh (Venous Intermittent Co, (2005). Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65: 865-869 [Abstract] [Full Text]  
• Chang, S. M., Parney, I. F., Huang, W., Anderson, F. A. Jr, Asher, A. L., Bernstein, M., Lillehei, K. O., Brem, H., Berger, M. S., Laws, E. R., for the Glioma Outcomes Project Investigators, (2005). Patterns of Care for Adults With Newly Diagnosed Malignant Glioma. JAMA 293: 557-564 [Abstract] [Full Text]  
• Agnelli, G. (2004). Prevention of Venous Thromboembolism in Surgical Patients. Circulation 110: IV-4-IV-12 [Abstract] [Full Text]  
• McGuire, M., Dobesh, P. P. (2004). Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism. Journal of Pharmacy Practice 17: 289-307 [Abstract]  
• Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., Ray, J. G. (2004). Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 338S-400S [Abstract] [Full Text]  
• Aronow, W. S. (2004). The Prevention of Venous Thromboembolism in Older Adults: Guidelines. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: M42-47 [Abstract] [Full Text]  
• Ross, I. B., Dhillon, G. S. (2003). Ventriculostomy-related Cerebral Hemorrhages after Endovascular Aneurysm Treatment. Am. J. Neuroradiol. 24: 1528-1531 [Abstract] [Full Text]  
• Nutescu, E. A, Lewis, R. K, Finley, J. M, Schumock, G. T (2003). Hospital Guidelines for Use of Low-Molecular-Weight Heparins. The Annals of Pharmacotherapy 37: 1072-1081 [Abstract] [Full Text]  
• Anderson, F. A. Jr., Spencer, F. A. (2003). Risk Factors for Venous Thromboembolism. Circulation 107: I-9-16 [Abstract] [Full Text]  
• Goldhaber, S. Z., Dunn, K., Gerhard-Herman, M., Park, J. K., Black, P. M. (2002). Low Rate of Venous Thromboembolism After Craniotomy for Brain Tumor Using Multimodality Prophylaxis. Chest 122: 1933-1937 [Abstract] [Full Text]  
• Norwood, S. H., McAuley, C. E., Berne, J. D., Vallina, V. L., Kerns, D. B., Grahm, T. W., Short, K., McLarty, J. W. (2002). Prospective Evaluation of the Safety of Enoxaparin Prophylaxis for Venous Thromboembolism in Patients With Intracranial Hemorrhagic Injuries. Arch Surg 137: 696-702 [Abstract] [Full Text]  
• Kelly, J., Rudd, A., Lewis, R.R., Hunt, B.J. (2001). Screening for subclinical deep-vein thrombosis. QJM 94: 511-519 [Full Text]  
• Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V. (2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Arterioscler. Thromb. Vasc. Bio. 21 : e9-e9 [Full Text]  
• Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V. (2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Circulation 103: 2994-3018 [Full Text]  
• Attia, J., Ray, J. G., Cook, D. J., Douketis, J., Ginsberg, J. S., Geerts, W. H. (2001). Deep Vein Thrombosis and Its Prevention in Critically Ill Adults. Arch Intern Med 161: 1268-1279 [Abstract] [Full Text]  
• Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., Dalen, J. E. (2001). Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety. Chest 119 : 64S-94S [Full Text]  
• Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A. Jr., Wheeler, H. B. (2001). Prevention of Venous Thromboembolism. Chest 119 : 132S-175S [Full Text]  
• Iorio, A., Agnelli, G. (2000). Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery: A Meta-analysis. Arch Intern Med 160: 2327-2332 [Abstract] [Full Text]  
• Aguilar, D., Goldhaber, S. Z. (1999). Clinical Uses of Low-Molecular-Weight Heparins. Chest 115: 1418-1423 [Full Text]  
• Connolly, E. S., Mocco, J, Agnelli, G., Iorio, A. (1998). Enoxaparin in Neurosurgical Patients. NEJM 339: 1639-1640 [Full Text]  
• (1998). Prophylactic Enoxaparin after Elective Neurosurgery. JWatch General 1998: 2-2 [Full Text]